Found: 29
Select item for more details and to access through your institution.
Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 8, p. 1, doi. 10.15252/emmm.202115230
- By:
- Publication type:
- Article
Rabies-based vaccine induces potent immune responses against Nipah virus.
- Published in:
- NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0109-5
- By:
- Publication type:
- Article
Rabies-based vaccine induces potent immune responses against Nipah virus.
- Published in:
- NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0109-5
- By:
- Publication type:
- Article
A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0023-7
- By:
- Publication type:
- Article
CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112060
- By:
- Publication type:
- Article
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo.
- Published in:
- Microorganisms, 2021, v. 9, n. 3, p. 566, doi. 10.3390/microorganisms9030566
- By:
- Publication type:
- Article
In Vivo Activity of Amodiaquine against Ebola Virus Infection.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56481-0
- By:
- Publication type:
- Article
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 7, p. 1, doi. 10.1371/journal.pntd.0007595
- By:
- Publication type:
- Article
Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, p. 1, doi. 10.1371/journal.pntd.0007454
- By:
- Publication type:
- Article
Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221407
- By:
- Publication type:
- Article
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
- Published in:
- Journal of Clinical Investigation, 2021, v. 131, n. 3, p. 1, doi. 10.1172/JCI144930
- By:
- Publication type:
- Article
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 326, p. 1, doi. 10.1126/scitranslmed.aaf1061
- By:
- Publication type:
- Article
On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 10, p. 2010, doi. 10.3390/v13102010
- By:
- Publication type:
- Article
Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 893, doi. 10.3390/v13050893
- By:
- Publication type:
- Article
Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b' Is Not Required for In Vitro Virus Replication.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 632, doi. 10.3390/v13040632
- By:
- Publication type:
- Article
A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 1, p. 52, doi. 10.3390/v13010052
- By:
- Publication type:
- Article
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 11, p. 655, doi. 10.3390/v10110655
- By:
- Publication type:
- Article
Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166318
- By:
- Publication type:
- Article
Specific Detection of Two Divergent Simian Arteriviruses Using RNAscope In Situ Hybridization.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151313
- By:
- Publication type:
- Article
Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Reorganization and expansion of the nidoviral family Arteriviridae.
- Published in:
- Archives of Virology, 2016, v. 161, n. 3, p. 755, doi. 10.1007/s00705-015-2672-z
- By:
- Publication type:
- Article
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 616, p. 1, doi. 10.1126/scitranslmed.abj5413
- By:
- Publication type:
- Article
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194880
- By:
- Publication type:
- Article